ClinicalTrials.Veeva

Menu

Femoral Artery Block for Reduction of Tourniquet Induced Hypertension

H

Hospital da Luz, Portugal

Status

Not yet enrolling

Conditions

Hypertension
Anesthesia, Conduction
Tourniquets
Anesthetics, Local

Treatments

Other: Femoral artery block

Study type

Interventional

Funder types

Other

Identifiers

NCT05954689
U1111-1293-7325

Details and patient eligibility

About

A randomised controlled trial to assess the impact of femoral artery block on the incidence of tourniquet hypertension in patients receiving cruciate ligament surgery with > 30 minutes of tourniquet under combined anaesthesia (balanced general anaesthesia and femoral nerve blocks).

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) physical status I to III
  • Receiving cruciate ligament surgery with > 30 minutes of tourniquet
  • Combined anesthesia (balanced general anesthesia and femoral nerve block)

Exclusion criteria

  • Nerve block contraindications (block site infection, allergic to local anesthetic)
  • Tourniquet contraindications (peripheral vascular disease or neuropathy, previous arterial bypass graft)
  • Tourniquet inflation time < 30 min
  • Patient refusal
  • Pregnant patients
  • Patients with a active psychiatric disease.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

50 participants in 2 patient groups

Femoral artery block
Experimental group
Description:
An experienced Anesthesiologist will perform the femoral blocks, under ultrasound guidance with a linear probe and a 50mm (millimeters) or 80mm needle. No nerve stimulator will be used during the block. In both groups, femoral nerve block at the nerve sheath will be performed with 20mL (milliliters) 0.5% ropivacaine. In the interventional group, additionally to the previous block, the needle will be retracted and advanced to the antero-medial side of the femoral artery where 10mL 0.5% ropivacaine will be injected after negative aspiration.
Treatment:
Other: Femoral artery block
No intervention
No Intervention group

Trial contacts and locations

0

Loading...

Central trial contact

Vasyl HDS Katerenchuk

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems